Opendata, web and dolomites

ZebraZoom SIGNED

ZebraZoom: Kinematic analysis for drug and genetic screening in zebrafish

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ZebraZoom project word cloud

Explore the words cloud of the ZebraZoom project. It provides you a very rough idea of what is the project "ZebraZoom" about.

suffering    screen    platform    decade    concluding    model    performed    genome    animals    degree    last    population    throughput    pain    70    resolution    mutant    posture    market    accuracy    devise    commercial    larvae    types    grant    starting    kinematics    dr    urgent    administration    relevance    screening    movement    with    neurodegenerative    homology    emerged    chronic    critical    marketing    drug    functions    ideal    fine    strength    zebrazoom    companies    labs    resolve    sensory    efficient    elaborate    juveniles    human    limited    disorders    quantitative    treatment    animal    resolved    kinematic    millions    disease    relies    molecules    optoloco    discovery    reliably    crude    defects    neurological    solutions    quantify    fast    citizens    movements    manipulations    genes    drugs    shares    behavioural    zebrafish    speed    genetic    plan    wyart    organism    humans    motor    business    erc    categorise    interpretation    models    poc    behavior    data    ways    diseases    pharmaceutical    consequently    investigation    suited    indicative   

Project "ZebraZoom" data sheet

The following table provides information about the project.

Coordinator
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE 

Organization address
address: BOULEVARD DE L'HOPITAL 47
city: PARIS
postcode: 75013
website: http://icm-institute.org/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-PoC
 Funding Scheme ERC-POC
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE FR (PARIS) coordinator 150˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

With millions of European citizens suffering from chronic pain and neurodegenerative disease, there is an urgent need for efficient solutions for drug screening in animal models. Discovery of new drugs and functions of genes involved in these human diseases relies on efficient ways to screen effects on animal behavior and at low cost. Zebrafish emerged in the last decade as an essential model for drug discovery as it is: i) a low cost genetic model organism whose genome shares 70% homology with human’s. ii) well-suited to fast and high throughput investigation of genes and molecules. iii) an ideal platform to study genes and pathways of relevance to disease in humans. Consequently, several companies are exploiting zebrafish research to devise new drugs for motor and neurological disorders. However, the current state of the art in commercial analysis of zebrafish behavior is limited to the analysis of crude parameters. In these conditions, the fast kinematics indicative of specific types of sensory and motor defects cannot be resolved. A fine kinematic analysis efficiently performed over large population of animals is crucial to reliably quantify defects in strength, posture or speed in mutant animals with and without with drug treatment. This accuracy is critical for concluding on the effects of drugs involved in motor functions, posture or pain. During her ERC starting grant OptoLoco, Dr. Wyart has developed ZebraZoom to resolve kinematic data with the necessary degree of resolution required for interpretation of motor defects. This approach enables the quantitative measurement of defects in speed, posture, and movement strength. In the ZebraZoom PoC, we will evaluate the market potential for a high-throughput method to quantify and categorise behavioural movements of zebrafish larvae/juveniles in response to drug administration and genetic manipulations and elaborate a marketing plan and business plan targeting for pharmaceutical companies and research labs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ZEBRAZOOM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ZEBRAZOOM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

EVOCELFATE (2019)

Evolution of cell fate specification modes in spiral cleavage

Read More  

inSight (2019)

Moving a novel gene therapy paradigm to treat blindness to the market

Read More  

ENTRAPMENT (2019)

Septins: from bacterial entrapment to cellular immunity

Read More